April 26-28, 2023
Chicago, IL

Important Dates and Information

Update your Online Booth. Click on "Edit Booth Info" below. ASAP
Early bird Deadline for Lead Retrieval (Compulead) 8/6/2021
Exhibitors with hotel room blocks - Deadline to provide guest names for the block. 8/10/2021
Advance Deadline for Lead Retrieval (Compulead) 8/23/2021
Last Day to Cancel Hotel Rooms without penalty. Review the Hotel & Travel page for details.  8/31/2021
Complete Exhibitor Appointed Contractor (EAC) Form if applicable and send it to mkutner@showmgmt.com 9/1/2021
Submit your Powerpoint slide to be included in the Keynote sessions. Please use the BOMA template. 9/3/2021
Request BOMA's press list to promote your presence at the Expo. Contact mkutner@showmgmt.com. 9/3/2021
Freeman Services Discount Deadline. This includes booth furnishings, labor, material handling, booth cleaning,etc. 9/7/2021
Advance shipments may start arriving at the Freeman warehouse 9/7/2021
REQUIRED: Submit a copy of your Certificate of Insurance (COI) to sales@rainprotection.net. Review the Liability insurance requirements for details.  9/7/2021
Deadline to reserve hotel rooms through the BOMA Housing Bureau at the Discounted Rate. Please note: the BOMA room block could sell out prior to this date. 9/12/2021
Advance Deadline for BCEC Services including: Electrical, Internet, Rigging, Plumbing. Click here to order online. 9/16/2021
Catering Order forms due to Levy. Click here to see the menus.  9/16/2021
Pre-Registration Deadline for Conference registrations & Booth personnel 9/17/2021
Discount Deadline for AV & Computer Rental (CCR Solutions) 9/22/2021
First Exhibitor Move in Day. Direct Shipments may begin to arrive at the BCEC at 8am 10/5/2021

KEYNOTE: Using AI to Transform Finding a Cure

  • Room: Sheraton 4-7, Level 4
  • Session Number:T100
Thursday,April 27, 2023:9:00 AM -10:15 AM

Speaker(s)

Keynote
Alice Zhang
CEO and Co-Founder
Verge Genomics

Description

Alice Zhang creates next-generation medicines from human genomics. She is CEO and Co-Founder of Verge Genomics, a new type of therapeutics company that takes a patient data-driven approach to unlock a whole spectrum of therapies that have escaped traditional drug discovery, beginning with diseases where patients need solutions the most: neurodegenerative disease. Prior to Verge, she spent seven years at the forefront of systems biology research at the National Cancer Institute, the Lewis-Sigler Institute for integrative Genomics at Princeton University, and UCLA, where she worked on gene networks involved in neuroregeneration. Alice will discuss how she is disrupting the system to treat the untreatable with artificial intelligence. She'll also share insights into the future of therapeutics, life sciences, biotech, and pharma.


Track: 


Sponsored by: